跳至主要内容
临床试验/NL-OMON53703
NL-OMON53703招募中不适用

Cognitive Functioning And Health Related Quality Of Life In Retinoblastoma Survivors: The Role Of Cancer Treatment And Repeated Anesthesia - RbNeuroQoL study

Amsterdam UMC0 个研究点目标入组 660 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
660

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
2 至 64(—)

入选标准

  • Cognitive functioning, psychosocial functioning and HRQoL in Rb survivors and
  • former Rb risk carriers (neuropsychological assessment and questionnaires):
  • In order to be eligible for inclusion the potential participant must meet all
  • inclusion criteria:
  • 1. Rb diagnosis, (main)treatment and follow-up of Rb patients and -survivors,
  • or Rb screening took place at the Dutch Retinoblastoma Expertise Center of the
  • Amsterdam University Medical Centers,
  • 2. Rb survivor or former Rb risk carriers is between 8 and 35 years old,
  • 3. Average understanding of the Dutch language.
  • Psychosocial wellbeing of the caregiver and pediatric trauma (only
  • questionnaires):
  • In order to be eligible for inclusion the potential participant must meet all
  • inclusion criteria:
  • 1. Being a caregiver of a Rb survivor or Rb risk carrier that have been
  • diagnosed and receive(d) (main) treatment and follow-up or screening at the
  • Dutch Retinoblastoma Expertise Center of the Amsterdam University Medical
  • 2. The related Rb survivor or Rb risk carrier is < 12 years old,
  • 3. Average understanding of the Dutch language.

排除标准

  • A potential participant who meets any of the following criteria will be
  • excluded from participation in this study:
  • 1. Pre-existing documented developmental delay and/or severe cognitive
  • impairments (IQ <70),
  • 2. Having an active, uncontrolled psychiatric illness,
  • 3. Rb diagnostic trajectory, treatment and follow-up at another hospital or
  • before the founding of the Dutch Retinoblastoom Expertise Center in 1991. With
  • exception of Rb survivors (diagnosed >1991) who apart from treatment at the
  • Dutch Retinoblastoma Center also required specialized treatment (such as
  • radiation) at another center: they are illegible for inclusion.

研究者

发起方
Amsterdam UMC

相似试验